<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diamond Blackfan <z:hpo ids='HP_0001903'>anemia</z:hpo> (<z:chebi fb="28" ids="35299">DBA</z:chebi>) is an inherited <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndrome characterized by red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> and congenital anomalies </plain></SENT>
<SENT sid="1" pm="."><plain>A predisposition to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> has been suggested but not quantified by case reports </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:chebi fb="28" ids="35299">DBA</z:chebi> Registry of North America (DBAR) is the largest established <z:chebi fb="28" ids="35299">DBA</z:chebi> patient cohort, with prospective follow-up since 1991 </plain></SENT>
<SENT sid="3" pm="."><plain>This report presents the first quantitative assessment of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence in <z:chebi fb="28" ids="35299">DBA</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Among 608 patients with 9458 person-years of follow-up, 15 solid <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, 2 <z:hpo ids='HP_0004808'>acute myeloid leukemias</z:hpo>, and 2 cases of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> were diagnosed at a median age of 41 years in patients who had not received a bone marrow transplant </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> incidence in <z:chebi fb="28" ids="35299">DBA</z:chebi> was significantly elevated </plain></SENT>
<SENT sid="6" pm="."><plain>The observed-to- expected ratio for <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> combined was 5.4 (P &lt; .05); significant observed-to-expected ratios were 287 for <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, 28 for <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, 36 for colon <z:mp ids='MP_0002038'>carcinoma</z:mp>, 33 for <z:hpo ids='HP_0002669'>osteogenic sarcoma</z:hpo>, and 12 for female <z:e sem="disease" ids="C0814141" disease_type="Neoplastic Process" abbrv="">genital cancers</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The median survival was 56 years, and the cumulative incidence of <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumor</z:e>/<z:hpo ids='HP_0001909'>leukemia</z:hpo> was approximately 20% by age 46 years </plain></SENT>
<SENT sid="8" pm="."><plain>As in Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:mp ids='MP_0009563'>dyskeratosis</z:mp> congenita, <z:chebi fb="28" ids="35299">DBA</z:chebi> is both an inherited <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndrome and a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> predisposition syndrome; <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risks appear lower in <z:chebi fb="28" ids="35299">DBA</z:chebi> than in Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> or <z:mp ids='MP_0009563'>dyskeratosis</z:mp> congenita </plain></SENT>
<SENT sid="9" pm="."><plain>This trial was registered at www.clinicaltrials.gov as #NCT00106015 </plain></SENT>
</text></document>